H Lukka

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group
    Eric Winquist
    Department of Medical Oncology, London Health Sciences Centre, London, Ontario, Canada
    BMC Cancer 6:112. 2006
  2. ncbi Randomized trial comparing two fractionation schedules for patients with localized prostate cancer
    Himu Lukka
    Radiation Oncology Program, Juravinski Cancer Centre, McMaster University, 699 Concession St, Hamilton, Ontario, Canada, L8V 5C2
    J Clin Oncol 23:6132-8. 2005
  3. ncbi Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis
    H Lukka
    Hamilton Regional Cancer Centre, Ontario, Canada
    Clin Oncol (R Coll Radiol) 14:203-12. 2002
  4. ncbi High-intensity focused ultrasound for prostate cancer: a systematic review
    H Lukka
    Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada
    Clin Oncol (R Coll Radiol) 23:117-27. 2011
  5. ncbi Controversies in prostate cancer radiotherapy: consensus development
    H Lukka
    Hamilton Regional Cancer Centre, Ontario, Canada
    Can J Urol 8:1314-22. 2001
  6. ncbi Management of stage I seminomatous testicular cancer: a systematic review
    P Chung
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network and University of Toronto, Toronto, Ontario, Canada
    Clin Oncol (R Coll Radiol) 22:6-16. 2010
  7. ncbi Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline
    R Segal
    Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada
    Can J Urol 8:1184-92. 2001
  8. ncbi Cutaneous metastasis of papillary serous uterine cancer
    L Elit
    Department of Obstetrics and Gynecology, Hamilton Regional Cancer Centre, Hamilton, Canada
    Gynecol Oncol 82:208-11. 2001
  9. ncbi Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin
    C Caney
    Department of Physics and Astronomy, McMaster University, Hamilton, Ontario, Canada
    Int J Radiat Biol 80:291-9. 2004
  10. ncbi Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer
    J Crook
    Princess Margaret Hospital, Toronto, Ont
    CMAJ 164:975-81. 2001

Collaborators

Detail Information

Publications12

  1. ncbi Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group
    Eric Winquist
    Department of Medical Oncology, London Health Sciences Centre, London, Ontario, Canada
    BMC Cancer 6:112. 2006
    ..the impetus for a systematic review addressing the following question: which non-hormonal systemic therapies are most beneficial for the treatment of men with hormone-refractory prostate cancer (HRPC) and clinical evidence of metastases?..
  2. ncbi Randomized trial comparing two fractionation schedules for patients with localized prostate cancer
    Himu Lukka
    Radiation Oncology Program, Juravinski Cancer Centre, McMaster University, 699 Concession St, Hamilton, Ontario, Canada, L8V 5C2
    J Clin Oncol 23:6132-8. 2005
    ..The optimal radiation dose fractionation schedule for localized prostate cancer is unclear. This study was designed to compare two dose fractionation schemes (a shorter 4-week radiation schedule v a longer 6.5-week schedule)...
  3. ncbi Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis
    H Lukka
    Hamilton Regional Cancer Centre, Ontario, Canada
    Clin Oncol (R Coll Radiol) 14:203-12. 2002
    ..To evaluate the role of concurrent cisplatin plus radiotherapy in the treatment of cervical cancer...
  4. ncbi High-intensity focused ultrasound for prostate cancer: a systematic review
    H Lukka
    Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada
    Clin Oncol (R Coll Radiol) 23:117-27. 2011
    ..Until results from case series are confirmed in prospective studies, the widespread use of HIFU is not supported...
  5. ncbi Controversies in prostate cancer radiotherapy: consensus development
    H Lukka
    Hamilton Regional Cancer Centre, Ontario, Canada
    Can J Urol 8:1314-22. 2001
    ..The consensus meeting strongly endorsed continued accrual to current studies investigating clinically relevant questions...
  6. ncbi Management of stage I seminomatous testicular cancer: a systematic review
    P Chung
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network and University of Toronto, Toronto, Ontario, Canada
    Clin Oncol (R Coll Radiol) 22:6-16. 2010
    ..The currently available evidence should be presented to patients in order to select the most appropriate option for the individual...
  7. ncbi Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline
    R Segal
    Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada
    Can J Urol 8:1184-92. 2001
    ....
  8. ncbi Cutaneous metastasis of papillary serous uterine cancer
    L Elit
    Department of Obstetrics and Gynecology, Hamilton Regional Cancer Centre, Hamilton, Canada
    Gynecol Oncol 82:208-11. 2001
    ..Cutaneous metastases from uterine cancer are uncommon. They usually indicate the aggressive nature of the underlying disease...
  9. ncbi Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin
    C Caney
    Department of Physics and Astronomy, McMaster University, Hamilton, Ontario, Canada
    Int J Radiat Biol 80:291-9. 2004
    ..In contrast, the subsequent cisplatin treatment of SCC-25 cells can enhance their survival following low radiation doses...
  10. ncbi Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer
    J Crook
    Princess Margaret Hospital, Toronto, Ont
    CMAJ 164:975-81. 2001
    ..Brachytherapy should be available to selected patients (those with T1c or T2a tumours, a Gleason score of 6 or lower and a serum PSA level of 10 micrograms/L or less), after discussion of the available data and potential adverse effects...
  11. ncbi Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis
    H Lukka
    Clin Oncol (R Coll Radiol) 16:160-1. 2004
  12. ncbi Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix
    R Pearcey
    Department of Oncology, University of Alberta, Edmonton, Canada
    J Clin Oncol 20:966-72. 2002
    ..To test the hypothesis that cisplatin (CDDP) administered concurrently with standard radiotherapy (RT) would improve pelvic control and survival in patients with advanced squamous cell cancer of the cervix...